Showing 1,181 - 1,200 results of 16,418 for search '"Therapy"', query time: 0.13s Refine Results
  1. 1181
  2. 1182
  3. 1183

    Cellular Programming and Reprogramming: Sculpting Cell Fate for the Production of Dopamine Neurons for Cell Therapy by Julio C. Aguila, Eva Hedlund, Rosario Sanchez-Pernaute

    Published 2012-01-01
    “…Pluripotent stem cells are regarded as a promising cell source to obtain human dopamine neurons in sufficient amounts and purity for cell replacement therapy. Importantly, the success of clinical applications depends on our ability to steer pluripotent stem cells towards the right neuronal identity. …”
    Get full text
    Article
  4. 1184

    Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy by Sol Jin, So Yun Lim, Yun Woo Lee, Heungsup Sung, Mi-Na Kim, Seongman Bae, Jiwon Jung, Min Jae Kim, Sung-Han Kim, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Eun Hee Song, Yong Pil Chong

    Published 2025-02-01
    “…Previous case reports have documented breakthrough bloodstream infections (BSI) during tigecycline therapy. This study aimed to investigate the incidence of, and risk factors for, breakthrough BSI during tigecycline monotherapy. …”
    Get full text
    Article
  5. 1185

    Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus by Ignacio Marin-Jimenez, Guillermo Bastida, Daniel Carpio, Fernando Muñoz, Yago González-Lama, Elena Ricart, Daniel Ceballos, Daniel Ginard, Luis Menchen

    Published 2024-01-01
    “…These statements cover: (1) use of first-line non-anti-TNF biological therapy; (2) role of HLA-DQA1*05 in daily practice; (3) attitudes in primary non-response and loss of response to anti-TNF therapy due to immunogenicity; (4) use of ustekinumab or vedolizumab if a change in action mechanism is warranted; (5) anti-TNF drug level monitoring; (6) combined therapy with an immunomodulator.Conclusion This document sought to pull together the best evidence, experts’ opinions, and treating physicians’ attitudes when using anti-TNF therapies in patients with CD.…”
    Get full text
    Article
  6. 1186

    Role of epigenetics in aetiology and therapies for Type 1 Diabetes Mellitus: A narrative review by Yahaya O Tajudeen, Ufuoma B Shemishere

    Published 2019-07-01
    Subjects: “…Type 1; DNA methylation; epigenomics; genetic therapy; hyperglycemia; microRNAs.…”
    Get full text
    Article
  7. 1187
  8. 1188

    The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study by Mahvish Muzaffar, Helen M. Johnson, Nasreen A. Vohra, Darla Liles, Jan H. Wong

    Published 2018-01-01
    “…The impact of locoregional therapy on survival in IBC is controversial. Methods. …”
    Get full text
    Article
  9. 1189

    Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia by Misako Kanayama, Maiko Hayashida, Sadayuki Hashioka, Tsuyoshi Miyaoka, Masatoshi Inagaki

    Published 2019-01-01
    “…We observed a change in the gut microbiota of a patient with schizophrenia after administering electroconvulsive therapy (ECT). A 59-year-old woman was diagnosed with schizophrenia at 17 years of age and has been taking antipsychotic drugs since the diagnosis. …”
    Get full text
    Article
  10. 1190

    Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy by Casimir de Rham, Jean Villard

    Published 2014-01-01
    “…Great hopes have been placed on human pluripotent stem (hPS) cells for therapy. Tissues or organs derived from hPS cells could be the best solution to cure many different human diseases, especially those who do not respond to standard medication or drugs, such as neurodegenerative diseases, heart failure, or diabetes. …”
    Get full text
    Article
  11. 1191

    Sinus Venosus Atrial Septal Defect Complicated by Eisenmenger Syndrome and the Role of Vasodilator Therapy by Amornpol Anuwatworn, Maheedhar Gedela, Edgard Bendaly, Julia A. Prescott-Focht, Jimmy Yee, Richard Clark, Orvar Jonsson

    Published 2016-01-01
    “…This case illustrates the potential benefit of vasodilator therapy in reversing Eisenmenger physiology, which may lead to surgical repair of the atrial septal defect as the primary treatment.…”
    Get full text
    Article
  12. 1192
  13. 1193
  14. 1194

    Study of Protein Biomarkers of Diabetes Mellitus Type 2 and Therapy with Vitamin B1 by Samreen Riaz

    Published 2015-01-01
    “…Some proteins were up- and downregulated in diabetic samples as compared to control and decreased after thiamine therapy, while other protein markers did not show a significant change after the thiamine therapy. …”
    Get full text
    Article
  15. 1195

    Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy by S. N. Mekhdiyev, O. A. Mekhdieva, O. M. Berko

    Published 2022-12-01
    “…Aim: to review the common risk factors and links in the pathogenesis of functional gastrointestinal disorders (FGID) to optimize therapy of patients with a combination of multiple FGID.Key points. …”
    Get full text
    Article
  16. 1196
  17. 1197

    <i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs by V. T. Ivashkin, T. L. Lapina

    Published 2012-11-01
    “…To demonstrate value of H. pylori eradication therapy in patients for prophylaxis and treatment of nonsteroid antiinflammatory drugs (NSAID)- induced gastropathies.Key points. …”
    Get full text
    Article
  18. 1198
  19. 1199
  20. 1200